Nacka, Stockholm: – Swedish-based turn key solution provider of modular facilities and process equipment’s within the pharma and biotech industries, Pharmadule Morimatsu AB (Pharmadule) has started to execute an order from a global biotech company to complete a Basic Design study for a biopharmaceutical project in Asia.

The biopharmaceutical basic design study will be coordinated and leaded by the well experienced and recognized Pharmadule Front End Engineering and Project Management Teams working in Nacka office in Sweden with support from the strong division Teams in Shanghai. The work started in end of June 2018 and will be completed in Q4 2018.

Multidisciplinary expertise

The study will harness multidisciplinary expertise, including Process and Facility Engineering, Quality Assurance, QbD and Regulatory compliance. It draws on Pharmadule Morimatsu’s rich experience in modular construction, process equipment, engineering and design in facility engineering and commissioning worldwide in which quality is inbuilt to every part of the operation.

About Pharmadule Morimatsu

Pharmadule Morimatsu designs and builds turnkey production facilities and process equipment’s for the pharma – biopharma Industries and also for the FMCG area (Fast Moving Consumer Goods). Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.

The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready-made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.

Since then, Pharmadule has successfully delivered more than 70 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pfizer, AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, which specializes in process equipment, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.